HOME › DRUGS › RETAPAMULIN
ACTIVE SUBSTANCE / INN

RETAPAMULIN

Brand name(s): Altargo, ALTABAX
FDA LISTED
EMA LISTED
WITHDRAWN
DISCONTINUED
NDA022055
Impetigo;Staphylococcal Skin Infections
ACTIVE SUBSTANCE
Retapamulin
REGULATORS
FDA · EMA
SPONSORS / MAH
ALMIRALL, Glaxo Group Ltd
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ALTABAXNDA022055ALMIRALLDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
AltargoGlaxo Group LtdWithdrawn24/05/2007Impetigo;Staphylococcal Skin Infections

FULL INTELLIGENCE ON RETAPAMULIN

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →